Sri Ramachandra Medical Centre is a tertiary care multi-specialty university hospital in Chennai, India. With over 1,500 beds, 114 ICU beds, 25 operating rooms, and a campus spread over 175 acres, SRMC is one of the largest private health care facilities in South Asia. It is located in the suburb of Porur.

There are 1,800 beds in Sri Ramachandra Medical Centre.

During the past decade, Sri Ramachandra Medical Centre conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sri Ramachandra Medical Centre" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "AtheroGenics" with 1 trials sponsored, "Ayana Pharma Ltd.," with 1 trials sponsored, "CymaBay Therapeutics, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sri Ramachandra Medical Centre" #1 collaborator was "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator, "Laboratorio Elea Phoenix S.A." with 1 trials as a collaborator, "Lambda Therapeutic Research Ltd." with 1 trials as a collaborator and "Libbs Farmacêutica LTDA" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sri Ramachandra Medical Centre" are "Cardiovascular Diseases" (1 trials), "Diabetes" (1 trials), "Diabetic Foot Ulcer" (1 trials), "Fallopian Tube Neoplasms" (1 trials) and "Metastatic Colorectal Cancer (mCRC)" (1 trials). Many other conditions were trialed in "Sri Ramachandra Medical Centre" in a lesser frequency.

Most popular intervention types in "Sri Ramachandra Medical Centre" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AGI-1067" (1 trials), "Actos" (1 trials), "Avastin® (bevacizumab, reference product)" (1 trials) and "BRV-PV Lot A + DPT-HepB-Hib + OPV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sri Ramachandra Medical Centre" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sri Ramachandra Medical Centre". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sri Ramachandra Medical Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sri Ramachandra Medical Centre, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".